AARTI DRUGS
Back to Cashflow Statement
|
AARTI DRUGS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹359 Cr | ₹133 Cr | ₹70 Cr | ₹155 Cr | ₹251 Cr |
What is the latest Cash Flow from Operating Activities ratio of AARTI DRUGS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹359 Cr |
Mar2023 | ₹133 Cr |
Mar2022 | ₹70 Cr |
Mar2021 | ₹155 Cr |
Mar2020 | ₹251 Cr |
How is Cash Flow from Operating Activities of AARTI DRUGS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹359 Cr | 169.22 | |
Mar2023 | ₹133 Cr | 89.34 | |
Mar2022 | ₹70 Cr | -54.56 | |
Mar2021 | ₹155 Cr | -38.20 | |
Mar2020 | ₹251 Cr | - |
Compare Cash Flow from Operating Activities of peers of AARTI DRUGS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI DRUGS | ₹4,624.8 Cr | -5.9% | 4.8% | 2.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,219.0 Cr | 0.4% | 1.7% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,227.0 Cr | -0.3% | -3.8% | 35.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,643.0 Cr | 3.9% | 11.8% | 20% | Stock Analytics | |
CIPLA | ₹125,541.0 Cr | 1.5% | 3.8% | 2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,063.0 Cr | -0.5% | -0.1% | -5.1% | Stock Analytics |
AARTI DRUGS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI DRUGS | -5.9% |
4.8% |
2.6% |
SENSEX | -1.2% |
-3% |
-0.2% |
You may also like the below Video Courses